المؤلفون: Sánchez A; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain., García-Pardo G; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Rovira i Virgili (URV), Tarragona, Spain., Gómez-Bertomeu F; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Rovira i Virgili (URV), Tarragona, Spain., López-Dupla M; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Rovira i Virgili (URV), Tarragona, Spain., Foguet-Romero E; Eurecat, Centre Tecnologic de Catalunya, Centre for Omic Sciences (Joint Unit Eurecat - Universitat Rovira i Virgili), Unique Scientific and Technical Infrastructure (ICTS), Reus, Spain., Buzón MJ; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Infectious Diseases Department, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, (VHIR) Task Force COVID-19, Barcelona, Spain., Almirante B; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Olona M; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Rovira i Virgili (URV), Tarragona, Spain., Fernández-Veledo S; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Universitat Rovira i Virgili (URV), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Vidal F; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Rovira i Virgili (URV), Tarragona, Spain., Chafino S; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Rull A; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Rovira i Virgili (URV), Tarragona, Spain., Peraire J; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Rovira i Virgili (URV), Tarragona, Spain.

مؤلفون مشاركون: COVIDOMICS Study Group

المصدر: IScience [iScience] 2023 Sep 19; Vol. 26 (10), pp. 107948. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

المؤلفون: Palau M; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Muñoz E; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain., Gusta MF; Institut Català de Nanociència i Nanotecnologia (ICN2), CSIC, The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, Barcelona, Spain.; Vall d'Hebron University Hospital, Barcelona, Spain.; CIBER en Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, Madrid, Spain., Larrosa N; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; Microbiology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Gomis X; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Gilabert J; Tractivus SL, Barcelona, Spain., Almirante B; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Puntes V; Institut Català de Nanociència i Nanotecnologia (ICN2), CSIC, The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, Barcelona, Spain.; Vall d'Hebron University Hospital, Barcelona, Spain.; CIBER en Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Texidó R; Grup d'Enginyeria de Materials (GEMAT), Universitat Ramón Llull, Barcelona, Spain., Gavaldà J; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

المصدر: Microbiology spectrum [Microbiol Spectr] 2023 Jun 15; Vol. 11 (3), pp. e0028023. Date of Electronic Publication: 2023 Apr 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE

مواضيع طبية MeSH: Metal Nanoparticles*/chemistry , Hyperthermia, Induced*, Amikacin/pharmacology ; Silver/pharmacology ; Silver/chemistry ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/chemistry ; Biofilms

المؤلفون: Palau M; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute, Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Muñoz E; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute, Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain., Larrosa N; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; Microbiology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Gomis X; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute, Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Márquez E; Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain., Len O; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute, Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Almirante B; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute, Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Gavaldà J; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute, Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

المصدر: Microbiology spectrum [Microbiol Spectr] 2023 Feb 14; Vol. 11 (1), pp. e0280722. Date of Electronic Publication: 2022 Dec 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE

مواضيع طبية MeSH: Methicillin-Resistant Staphylococcus aureus* , Pneumonia, Ventilator-Associated*/etiology , Pneumonia, Ventilator-Associated*/prevention & control , Hyperthermia, Induced*/adverse effects, Humans ; Animals ; Rabbits ; Intubation, Intratracheal/adverse effects ; Anti-Bacterial Agents ; Biofilms ; Pseudomonas aeruginosa

المؤلفون: Suanzes P; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain., Willekens R; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain., Puig-Asensio M; Infectious Diseases Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, Barcelona, Spain; Spanish Network for the Study of Infectious Diseases (REIPI), Spain., Pizzi MN; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain; Cardiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Roque A; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain; Radiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Barios M; Nuclear Medicine Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Simó M; Nuclear Medicine Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Rodríguez-Pardo D; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain; Spanish Network for the Study of Infectious Diseases (REIPI), Spain., Larrosa MN; Spanish Network for the Study of Infectious Diseases (REIPI), Spain; Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Fernández-Hidalgo N; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain; Spanish Network for the Study of Infectious Diseases (REIPI), Spain. Electronic address: nufernan@gmail.com., Almirante B; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain; Spanish Network for the Study of Infectious Diseases (REIPI), Spain.

المصدر: Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2023 Jan; Vol. 41 (1), pp. 3-10. Date of Electronic Publication: 2022 Oct 29.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 101777541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2529-993X (Electronic) Linking ISSN: 2529993X NLM ISO Abbreviation: Enferm Infecc Microbiol Clin (Engl Ed) Subsets: MEDLINE

مواضيع طبية MeSH: Staphylococcal Infections*/diagnostic imaging , Staphylococcal Infections*/drug therapy , Bacteremia*/diagnostic imaging , Bacteremia*/drug therapy, Adult ; Humans ; Aged ; Positron Emission Tomography Computed Tomography ; Fluorodeoxyglucose F18 ; Staphylococcus aureus ; Prospective Studies ; Anti-Bacterial Agents/therapeutic use

المؤلفون: Morata L; Service of Infectious Diseases, Hospital Clínic Barcelona, Calle de Villarroel, 170, Spain., Aguado JM; Infectious Diseases Unit, Hospital Universitario 12 de Octubre, Avenida de Córdoba, s/n, Spain., Salavert M; Infectious Diseases Unit, Hospital Universitari i Politècnic La Fe, Avinguda de Fernando Abril Martorell, 106, Spain., Pasquau J; Department of Infectious Diseases, Hospital Universitario Virgen de las Nieves, Avenida de las Fuerzas Armadas, 2, Spain., Míguez E; Division of Infectious Diseases, Hospital Universitario A Coruña, As Xubias 84, A Coruña 15006, Spain., Muñoz P; Department of Medical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, Spain., Rosselló I; Medical Department, Angelini Pharma España, Calle Antonio Machado, 78-80, Edificio Australia-3a planta, Viladecans 08840, Spain., Almirante B; Hospital Universitario Vall d'Hebrón, Passeig de la Vall d'Hebron, 119, Barcelona 08035, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, Madrid 28029, Spain.

المصدر: JAC-antimicrobial resistance [JAC Antimicrob Resist] 2022 Dec 22; Vol. 4 (6), pp. dlac120. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101765283 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1823 (Electronic) Linking ISSN: 26321823 NLM ISO Abbreviation: JAC Antimicrob Resist Subsets: PubMed not MEDLINE

المؤلفون: Roso-Llorach A; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gorina (IDIAPJGol), Barcelona, Catalonia, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain., Serra-Picamal X; Institut Català de la Salut (ICS), Barcelona, Catalonia, Spain., Cos FX; Institut Català de la Salut (ICS), Barcelona, Catalonia, Spain., Pallejà-Millán M; Unitat de Suport a la Recerca Tarragona-Reus, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Reus, Catalonia, Spain., Mateu L; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.; Universitat de Vic-UCC, Vic, Catalonia, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain., Rosell A; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.; Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.; Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Catalonia, Spain., Almirante B; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.; Spanish Network for Research in Infectious Disease (REIPI), Instituto de Salud Carlos III, Madrid, Spain., Ferrer J; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.; Department of Respiratory Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain., Gasa M; Department of Respiratory Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalonia, Spain.; Institut d'investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Catalonia, Spain.; University of Barcelona, Barcelona, Catalonia, Spain., Gudiol C; Institut d'investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Catalonia, Spain.; University of Barcelona, Barcelona, Catalonia, Spain.; Infectious Diseases Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalonia, Spain., Moreno AM; Hospital Universitari Arnau de Vilanova, IRBL, Lleida, Catalonia, Spain., Morales-Rull JL; Hospital Universitari Arnau de Vilanova, IRBL, Lleida, Catalonia, Spain., Rexach M; Department of Internal Medicine, Hospital Universitari Doctor Josep Trueta, Girona, Catalonia, Spain.; Internal Medicine Research Group, Institut d'investigació Biomèdica de Girona - IDIBGI, Girona, Catalonia, Spain., Sabater G; Department of Internal Medicine, Hospital Universitari Doctor Josep Trueta, Girona, Catalonia, Spain., Auguet T; Hospital Universitari de Tarragona Joan XXIII, Tarragona, Catalonia, Spain.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Catalonia, Spain.; Universitat Rovira i Virgili, Tarragona, Catalonia, Spain., Vidal F; Hospital Universitari de Tarragona Joan XXIII, Tarragona, Catalonia, Spain.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Catalonia, Spain.; Universitat Rovira i Virgili, Tarragona, Catalonia, Spain., Lerida A; Hospital de Viladecans, Viladecans, Catalonia, Spain., Rebull J; Hospital Universitari Verge de la Cinta, Tortosa, Catalonia, Spain., Khunti K; Diabetes Research Center, University of Leicester, Leicester General Hospital, Leicester, UK., Argimon JM; Institut Català de la Salut (ICS), Barcelona, Catalonia, Spain., Paredes R; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.; Universitat de Vic-UCC, Vic, Catalonia, Spain.; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.; Center for Global Health & Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

المصدر: Global epidemiology [Glob Epidemiol] 2022 Dec; Vol. 4, pp. 100071. Date of Electronic Publication: 2022 Jan 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101759263 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-1133 (Electronic) Linking ISSN: 25901133 NLM ISO Abbreviation: Glob Epidemiol Subsets: PubMed not MEDLINE

المؤلفون: Palau M; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Muñoz E; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain., Lujan E; Electrochemical Methods Laboratory-Analytical and Applied Chemistry Department, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain., Larrosa N; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; Microbiology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Gomis X; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Márquez E; Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain., Len O; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Almirante B; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Abellà J; Electrochemical Methods Laboratory-Analytical and Applied Chemistry Department, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain., Colominas S; Electrochemical Methods Laboratory-Analytical and Applied Chemistry Department, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain., Gavaldà J; Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Spanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

المصدر: Microbiology spectrum [Microbiol Spectr] 2022 Oct 26; Vol. 10 (5), pp. e0236522. Date of Electronic Publication: 2022 Oct 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE

مواضيع طبية MeSH: Daptomycin*/pharmacology , Catheter-Related Infections*/drug therapy , Catheter-Related Infections*/microbiology , Anti-Infective Agents*/pharmacology, Rabbits ; Animals ; Vancomycin/pharmacology ; Hypochlorous Acid/pharmacology ; Saline Solution/pharmacology ; Saccharomyces cerevisiae ; Biofilms ; Staphylococcus epidermidis ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Microbial Sensitivity Tests

المؤلفون: Sempere A; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Viñado B; Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain., Los-Arcos I; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain., Campany D; Pharmacy Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Larrosa N; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Fernández-Hidalgo N; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Rodríguez-Pardo D; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., González-López JJ; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Nuvials X; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Critical Care Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Sepsis Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Almirante B; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Escolà-Vergé L; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Oct 18; Vol. 66 (10), pp. e0075122. Date of Electronic Publication: 2022 Sep 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Aztreonam*/therapeutic use , beta-Lactamases*, Humans ; Retrospective Studies ; Microbial Sensitivity Tests ; Anti-Bacterial Agents/therapeutic use ; Azabicyclo Compounds/therapeutic use ; Ceftazidime/therapeutic use ; Gram-Negative Bacteria ; Drug Combinations

المؤلفون: Escolà-Vergé L; Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Rello P; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Declerck C; Infectious Diseases Department, Angers University Hospital, Angers, France., Dubée V; Infectious Diseases Department, Angers University Hospital, Angers, France., Rouleau F; Department of Cardiology, Angers University Hospital, Angers, France., Duval X; Infectious Diseases, CIC Inserm 1425, IAME, Bichat Hospital, APHP, Paris Cité University, Paris, France., Habib G; Cardiology Department, La Timone Hospital, Aix Marseille University, IRD, APHM, Marseille, France., Lavie-Badie Y; Heart Valve Center, Toulouse University Hospital, Toulouse, France., Martin-Blondel G; Department of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, France., Porte L; Department of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, France., Bouiller K; Infectious Diseases, CHU Besancon, Besancon, France., Goehringer F; Infectious Diseases Department, Nancy University Hospital, Nancy, France., Selton-Suty C; Cardiology Department, CHU Nancy, Nancy, France., Lamas CDC; Infectious Diseases, Instituto Nacional de Cardiologia. Unigranrio. Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil., Nacinovich F; Infectious Diseases, Instituto Cardiovascular Buenos Aires, Buenos Aires, Argentina., Issa N; Infectious Diseases and ICU, Groupe Saint-André Hospital, University Hospital, Bordeaux, France., Richaud C; Internal Medecine, Institut Mutualiste Montsouris, Paris, France., Hammoudi N; Sorbonne Université, ACTION Study Group, INSERM UMR_S 1166, and Hôpital Pitié-Salpêtrière (AP-HP), Paris, France., Barranco FJ; Maternal Fetal Medicine Unit, Department of Obstetrics, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain., Almirante B; Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Tattevin P; Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes, France., Fernández-Hidalgo N; Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Sep 30; Vol. 77 (10), pp. 2701-2705.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Endocarditis*/drug therapy , Endocarditis*/epidemiology , Endocarditis, Bacterial*/drug therapy , Endocarditis, Bacterial*/epidemiology, Female ; Humans ; Infant ; Infant, Newborn ; Pregnancy ; Pregnant Women ; Retrospective Studies ; Staphylococcus

المؤلفون: Grossi AP; Department of Medicine and Surgery, Section of Infectious Diseases, University of Insubria, Varese, Italy., Ruggieri A; Αngelini Pharma S.p.A., Rome, Italy., Vecchio AD; Αngelini Pharma S.p.A., Rome, Italy., Comandini A; Αngelini Pharma S.p.A., Rome, Italy., Corio L; Αngelini Pharma S.p.A., Rome, Italy., Calisti F; Αngelini Pharma S.p.A., Rome, Italy., Loreto GD; Αngelini Pharma S.p.A., Rome, Italy., Almirante B; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Electronic address: balmirante@vhebron.net.

المصدر: International journal of antimicrobial agents [Int J Antimicrob Agents] 2022 Sep; Vol. 60 (3), pp. 106637. Date of Electronic Publication: 2022 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE

مواضيع طبية MeSH: Methicillin-Resistant Staphylococcus aureus* , Skin Diseases, Bacterial*/drug therapy , Skin Diseases, Bacterial*/epidemiology , Skin Diseases, Bacterial*/microbiology, Adult ; Anti-Bacterial Agents/pharmacology ; Europe/epidemiology ; Humans ; Incidence ; Retrospective Studies